JANUS HENDERSON GROUP PLC - 31 Dec 2024 SCHEDULE 13G/A Report for 4D Molecular Therapeutics, Inc. Common Stock (FDMT)

Filing Manager: JANUS HENDERSON GROUP PLC
Reporting Manager: JANUS HENDERSON GROUP PLC
Security: 4D Molecular Therapeutics, Inc. Common Stock
Symbol: FDMT
Shares outstanding: 45,964,082 shares
Disclosed Ownership: 2,252,240 shares
Ownership: 4.9%
Form type: SCHEDULE 13G/A
Filing time: 14 Feb 2025, 11:34:51 UTC
Date of event: 31 Dec 2024
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
JANUS HENDERSON GROUP PLC	4.9%	2,252,240	0	2,252,240	Kristin Mariani	Head of North America Compliance, CCO